Multidrug-resistant bacteria in solid organ transplant recipients (Q26822729)

main subject

multiple drug resistance

0 references

author

Carlos Cervera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Joan Gavaldà

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Murat Akova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Jordi Carratala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

C van Delden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

T Welte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

ESCMID Study Group for Infections in Compromised Hosts

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

1 reference

September 2014

1 reference

Clinical Microbiology and Infection

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

20 Suppl 7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

49-73

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24861521%20AND%20SRC:MED&resulttype=core&format=json

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Health care-associated invasive MRSA infections, 2005-2008.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Antibiotics for preventing recurrent urinary tract infection in non-pregnant women

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors for Staphylococcus aureus infection in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Biliary complications after living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Future directions in the management of tertiary peritonitis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

High serum concentrations of cyclosporin related to administration of tigecycline

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

High mortality related with Staphylococcus aureus bacteremia after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Acinetobacter mediastinitis in a heart transplant patient.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Hardware preservation after sternal wound infection in a lung transplant recipient

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Tigecycline: an update

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a heart transplant recipient

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infection control: the case for horizontal rather than vertical interventional programs

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The revival of fosfomycin

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bacteremia and septic shock after solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pneumonia in solid organ recipients: spectrum of pathogens in 217 episodes

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infections with blaKPC-2-producing Klebsiella pneumoniae in renal transplant patients: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Incisional surgical site infection in kidney transplantation.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Mediastinitis in heart and lung transplantation: 15 years experience

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Successful treatment of vancomycin resistant Enterococcus faecium mediastinitis associated with left ventricular assist devices.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Hepatic cyst infection in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Hepatobiliary excretion of fluconazole and its interaction with cyclosporin A in rat blood and bile using microdialysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pivmecillinam?therapy of choice for lower urinary tract infection

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bacterial mediastinitis after heart transplantation: clinical presentation, risk factors and treatment

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Vacuum-assisted closure therapy in mediastinitis after heart transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The role of nasal carriage in Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA).

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Relapse and reacquisition of rectal colonization by vancomycin-resistant Enterococcus faecium after decolonization

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Linezolid in the treatment of vancomycin‐resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate‐use trial

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Non-Heart Beating Donor Kidneys with Delayed Graft Function Have Superior Graft Survival Compared with Conventional Heart-Beating Donor Kidneys That Develop Delayed Graft Function

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pharmacokinetics of Meropenem Determined by Microdialysis in the Peritoneal Fluid of Patients With Severe Peritonitis Associated With Septic Shock

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Airway complications following lung transplantation - clinic, diagnosis, and interventional management

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Screening Inpatients for MRSA — Case Closed

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

An intervention to decrease catheter-related bloodstream infections in the ICU.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Genetic basis for in vivo daptomycin resistance in enterococci

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Targeted versus universal decolonization to prevent ICU infection

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Vancomycin-resistant enterococci: mechanisms and clinical observations

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Tigecycline: a new glycylcycline for treatment of serious infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Efficacy of infection control strategies to reduce transmission of vancomycin-resistant enterococci in a tertiary care hospital in Korea: a 4-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Progress and challenges in implementing the research on ESKAPE pathogens

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Excess deaths associated with tigecycline after approval based on noninferiority trials

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Summary of ceftaroline fosamil clinical trial studies and clinical safety

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

A study of the penetration of meropenem into bile using endoscopic retrograde cholangiography

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Severe myopathy and possible hepatotoxicity related to daptomycin

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

https://api.crossref.org/works/10.1111%2F1469-0691.12687

1 reference

7 January 2021

Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Efficacy and safety of tigecycline: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pathogenesis of early operative site infections after orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Outcome, Incidence, and Timing of Infectious Complications in Small Bowel and Multivisceral Organ Transplantation Patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Extended spectrum β-lactamase-producing Enterobacteriaceae infection in heart and lung transplant recipients and in mechanical circulatory support recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pulmonary infection defense after lung transplantation: does airway ischemia play a role?

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infection prevention and control in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The use of fosfomycin to treat urinary tract infections in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Biliary complications after liver transplantation: old problems and new challenges

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Surgical correction of vesico-ureteric reflux for recurrent febrile urinary tract infections after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Late anastomotic leaks in pancreas transplant recipients - clinical characteristics and predisposing factors

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Prospective study of infectious complications in a cohort of pediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Successful treatment of recurrent cholangitis complicating liver transplantation by Roux-en-Y limb lengthening

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Methicillin-resistant Staphylococcus aureus infection after living-donor liver transplantation in adults

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Incisional surgical infection in heart transplantation.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Efficacy and safety of linezolid in liver transplant patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Six-month incidence of bloodstream infections in intestinal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Surgical wound complications after heart transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Lung transplant infection

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Aspergillus infections in lung transplant recipients: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bloodstream Infections Among Transplant Recipients: Results of a Nationwide Surveillance in Spain

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Delay of adequate empiric antibiotic therapy is associated with increased mortality among solid-organ transplant patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Carbapenemase-producing Klebsiella pneumoniae-related mortality among solid organ-transplanted patients: do we know enough?

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Colistin distribution in the peritoneal fluid of a patient with severe peritonitis.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Human tissue distribution of voriconazole.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Ciprofloxacin activity in cyst fluid from polycystic kidneys

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Pediococcus acidilactici endocarditis successfully treated with daptomycin

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Heteroresistance to vancomycin in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

The current status of small bowel transplantation in the UK and internationally

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Outcomes of lung transplantation for cystic fibrosis in a large UK cohort.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Colistin interactions with the mammalian urothelium

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Risk factors for coexistence of fluoroquinolone resistance and ESBL production among Enterobacteriaceae in a Greek university hospital.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Inhaled colistin following lung transplantation in colonised cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Bloodstream infection following 217 consecutive systemic-enteric drained pancreas transplants

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Renal and neurological side effects of colistin in critically ill patients

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Peritoneal fluid penetration of tigecycline

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Acute interstitial nephritis associated with linezolid

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Effectiveness of hospital-wide methicillin-resistant Staphylococcus aureus (MRSA) infection control policies differs by ward specialty.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis.

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Cyst infections in patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Linezolid-induced interstitial nephritis in a kidney-transplant patient

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Prevention of intravascular catheter-related infections

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

1 reference

https://api.crossref.org/works/10.1111%2F1469-0691.12687

7 January 2021